Medication safety goes beyond labels and warnings. It’s built on real-world data, statistical analysis, and ongoing research to understand how drugs truly affect people. Learn how science identifies risks, benefits, and hidden dangers.
Daily aspirin for heart health is no longer recommended for most people. Learn who should avoid it, why guidelines changed in 2026, and what to do instead to protect your heart safely.
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease causing widespread inflammation. Learn its key symptoms, common triggers for flares, and evidence-based management strategies to control the disease and protect organ health.
Gut microbiota plays a key role in obesity by influencing energy extraction, inflammation, and metabolism. Probiotics, especially Lactobacillus gasseri and synbiotics, can support weight loss when combined with diet changes. Results vary, but consistent use shows measurable benefits.
Genetic testing for BRCA, Lynch syndrome, and other inherited cancer risks can guide life-saving prevention. Learn who should be tested, what results mean, and how modern panels are changing outcomes.
Secondary patents let pharmaceutical companies extend drug monopolies by protecting minor changes like formulations or new uses - delaying generics and keeping prices high. Here's how it works and why it matters.
Phototherapy is the most effective treatment for vitiligo, helping restore pigment in depigmented skin. Depigmentation is a separate, last-resort option for extensive cases. Learn how NB-UVB works, what to expect, and why combining treatments isn't recommended.
Learn how creatinine, eGFR, and urinalysis tests detect early kidney damage before symptoms appear. Understand what your numbers mean and how to protect your kidney health.
Learn the 2025 rules for bringing prescription and controlled medications across international borders. Avoid seizures, fines, or detention with step-by-step documentation tips for the U.S., EU, Japan, UAE, and more.
Europe led the world in biosimilar adoption with clear regulations and high uptake. The US lagged due to patents and strict rules-but is now accelerating fast. Here's how the two markets compare today and where they're headed.